Rose BioSolutions has appointed Anthony Mattacchione as Chief Financial Officer, bringing more than 20 years of senior finance leadership across biopharmaceuticals, life sciences, and technology. In his new role, Mattacchione will help guide the company’s financial strategy as it strengthens its business and supports clients advancing therapies toward commercialization.
About Anthony Mattacchione
Before joining Rose BioSolutions, Mattacchione served as Global CFO of CellCarta, where he led financial and operational transformation. He previously held CFO positions at Curia, Bruker, and MilliporeSigma, bringing experience in business growth, financial strategy, and organizational change.
Mattacchione holds an MBA in Finance from the University of Connecticut and a bachelor’s degree in Accountancy from Central Connecticut State University.
About Rose BioSolutions
Rose BioSolutions supports biopharmaceutical and life sciences companies navigating the path from clinical development to commercialization, particularly in the cell and gene therapy sector. The company focuses on the operational and business infrastructure needed to help developers bring advanced therapies to market.
